570 related articles for article (PubMed ID: 16033876)
1. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
4. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
Hsia J; Criqui MH; Rodabough RJ; Langer RD; Resnick HE; Phillips LS; Allison M; Bonds DE; Masaki K; Caralis P; Kotchen JM;
Circulation; 2004 Feb; 109(5):620-6. PubMed ID: 14769684
[TBL] [Abstract][Full Text] [Related]
5. Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial".
Willett WC; Manson JE; Grodstein F; Stampfer MJ; Colditz GA
Am J Epidemiol; 2006 Jun; 163(11):1067-8; author reply 1068-9. PubMed ID: 16641306
[No Abstract] [Full Text] [Related]
6. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG
Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990
[TBL] [Abstract][Full Text] [Related]
7. Estrogen plus progestin and the risk of coronary heart disease.
Manson JE; Hsia J; Johnson KC; Rossouw JE; Assaf AR; Lasser NL; Trevisan M; Black HR; Heckbert SR; Detrano R; Strickland OL; Wong ND; Crouse JR; Stein E; Cushman M;
N Engl J Med; 2003 Aug; 349(6):523-34. PubMed ID: 12904517
[TBL] [Abstract][Full Text] [Related]
8. A comparative review of the risks and benefits of hormone replacement therapy regimens.
Warren MP
Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
[TBL] [Abstract][Full Text] [Related]
9. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
10. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
11. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
12. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
Hendrix SL
J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
[No Abstract] [Full Text] [Related]
13. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
14. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
Shapiro S
Climacteric; 2003 Dec; 6(4):302-10; discussion 310-3. PubMed ID: 15006251
[TBL] [Abstract][Full Text] [Related]
15. Venous thrombosis and conjugated equine estrogen in women without a uterus.
Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
[TBL] [Abstract][Full Text] [Related]
16. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
17. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
Hsia J; Langer RD; Manson JE; Kuller L; Johnson KC; Hendrix SL; Pettinger M; Heckbert SR; Greep N; Crawford S; Eaton CB; Kostis JB; Caralis P; Prentice R;
Arch Intern Med; 2006 Feb; 166(3):357-65. PubMed ID: 16476878
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
Henderson VW
Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
[TBL] [Abstract][Full Text] [Related]
19. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.
Perez MV; Wang PJ; Larson JC; Virnig BA; Cochrane B; Curb JD; Klein L; Manson JE; Martin LW; Robinson J; Wassertheil-Smoller S; Stefanick ML
Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1108-16. PubMed ID: 23169946
[TBL] [Abstract][Full Text] [Related]
20. Estrogen plus progestin and colorectal cancer in postmenopausal women.
Chlebowski RT; Wactawski-Wende J; Ritenbaugh C; Hubbell FA; Ascensao J; Rodabough RJ; Rosenberg CA; Taylor VM; Harris R; Chen C; Adams-Campbell LL; White E;
N Engl J Med; 2004 Mar; 350(10):991-1004. PubMed ID: 14999111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
